First Hawaiian Bank’s Utah Medical Products UTMD Stock Holding History

First Hawaiian Bank’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,930	Closed	-$340K	–	889
2021 Q1	$340K	Hold	3,930	–	–	0.01%	672
2020 Q4	$331K	Hold	3,930	–	–	0.02%	630
2020 Q3	$314K	Hold	3,930	–	–	0.02%	581
2020 Q2	$348K	Hold	3,930	–	–	0.02%	532
2020 Q1	$370K	Hold	3,930	–	–	0.02%	458
2019 Q4	$424K	Sell	3,930 -360	-8%	-$36.5K	0.02%	535
2019 Q3	$411K	Hold	4,290	–	–	0.02%	535
2019 Q2	$411K	Buy	4,290 +1,100	+34%	+$92.6K	0.02%	524
2019 Q1	$282K	Buy	+3,190	New	+$280K	0.02%	637

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Hawaiian Bank's UTMD Position: Q2 2021 in Review

First Hawaiian Bank sold out of Utah Medical Products (UTMD) in Q2 2021, closing a stake of 3,930 shares — an estimated $340K sold.

First Hawaiian Bank first reported a position in UTMD in Q1 2019 and held it in 9 quarters. The position peaked at $424K in Q4 2019. 68 funds tracked by Wall St. Rank hold UTMD as of Q2 2021.

First Hawaiian Bank reported no remaining Utah Medical Products position as of Q2 2021 after selling out during the quarter.
First Hawaiian Bank sold 3,930 Utah Medical Products shares in Q2 2021, an estimated $340K.
First Hawaiian Bank first reported a position in Utah Medical Products in Q1 2019 and held it in 9 quarters.
First Hawaiian Bank's Utah Medical Products position peaked at $424K in Q4 2019.
68 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2021.

Based on First Hawaiian Bank's 13F filing for Q2 2021, filed 8 Jul 2021.